Question 1

What is the catalog number for Akt, phosphorylated (Y326) discontinued?

Accepted Answer

The catalog number for Akt, phosphorylated (Y326) discontinued is 340740.

Question 2

What sizes are available for Akt, phosphorylated (Y326) discontinued?

Accepted Answer

Akt, phosphorylated (Y326) discontinued is available in the following size(s): 100 µL, 200 µL.

Question 3

How many pack sizes does Akt, phosphorylated (Y326) discontinued come in?

Accepted Answer

Akt, phosphorylated (Y326) discontinued is available in 2 different pack sizes.

Question 4

Is Akt, phosphorylated (Y326) discontinued in stock?

Accepted Answer

Akt, phosphorylated (Y326) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Akt, phosphorylated (Y326) discontinued

Product Specifications

Clonality

Available Sizes

Frequently Asked Questions

Explore Other Products

Human MAP1 (MOAP1) activation kit by CRISPRa

XRCC4 (NM_022550) Human Recombinant Protein

NCAM1 / CD56 Recombinant Rabbit monoclonal Antibody

Isotype Control, Mouse IgG1 Kappa (IGG1/1331), CF640R Conjugate, 0.1 mg/mL

Human CC130 (CCDC130) activation kit by CRISPRa

Human ZNF605 activation kit by CRISPRa